Streetbeat News

Products Services

FMED

The biotech sector, which saw strong performance in 2020 and 2021, has faced challenges due to high interest rates and reduced deal-making. However, the outlook is improving, and the FMED ETF is highlighted as a potential investment opportunity in this disruptive space.

Portfolio Pulse from

December 12, 2024 | 9:15 pm

IVA

Inventiva, a clinical-stage biopharmaceutical company, announced the results of its Combined Shareholders' General Meeting held on December 11, 2024. The company is focused on developing therapies for metabolic dysfunction-associated steatohepatitis (MASH) and other diseases.

Portfolio Pulse from

December 12, 2024 | 9:15 pm

CNP

CenterPoint Energy is making significant progress in the second phase of its Greater Houston Resiliency Initiative, having installed over 7,000 stronger poles in less than 100 days. This initiative aims to improve reliability and reduce outage minutes for customers.

Portfolio Pulse from

December 12, 2024 | 9:00 pm

RIOT

Starboard Value has taken a stake in Riot Platforms (RIOT) with plans to pivot the company deeper into the A.I. space by converting some crypto-mining facilities for hyperscalers.

Portfolio Pulse from

December 12, 2024 | 9:00 pm

SBMCF

Silver Bullet Mines Corp. continues to report high-grade silver assay results from its Super Champ project in Arizona, with some assays showing over 1000 oz/ton of silver and visible gold in mill concentrates.

Portfolio Pulse from

December 12, 2024 | 9:00 pm

S

SentinelOne, Inc. participated in the Barclays 22nd Annual Global Technology Conference, with key company figures like CEO Tomer Weingarten and VP of Investor Relations Doug Clark present. The event included discussions with Barclays' Saket Kalia.

Portfolio Pulse from

December 12, 2024 | 8:45 pm

MNTL

The article discusses the importance of tech investing, particularly in the context of the Neuroscience ETF MNTL, as investors approach 2025. It highlights the significant returns tech firms have provided but also raises concerns about potential concentration risks.

Portfolio Pulse from

December 12, 2024 | 8:45 pm

BIOA

Levi & Korsinsky has initiated an investigation into BioAge Labs, Inc. (NASDAQ:BIOA) for potential violations of federal securities laws following the discontinuation of its STRIDES Phase 2 trial for azelaprag due to safety concerns.

Portfolio Pulse from

December 12, 2024 | 8:45 pm

ACRV

Acrivon Therapeutics is making progress in developing a targeted oncology therapy for gynecologic cancers, with promising clinical trial updates. The company is financially stable to advance its pipeline, though biotech investment risks remain.

Portfolio Pulse from

December 12, 2024 | 8:45 pm

CGC

STORZ & BICKEL, a subsidiary of Canopy Growth Corporation, made history as the first vaporizer brand to sponsor NYLON House during Miami Art Week. Their latest device, VENTY, was awarded Vaporizer of the Year at the 2024 EMJAYS International Cannabis Awards.

Portfolio Pulse from

December 12, 2024 | 8:30 pm